electroCore Announces Full Year 2025 Financial Results and Organizational Changes
Stocks in this Quantisnow insightHealth Care
Historical context for ECOR
Across the 8 sessions after earlier ECOR headlines, the stock closed higher 4 times and lower 4 times, with a median move of 2.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ECOR | SPY |
|---|---|---|---|
| Mar 10, 2026 | electroCore to Participate at the 38th Annual Roth Conference | -2.1% | -0.2% |
| Mar 9, 2026 | electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026 | -3.1% | +0.9% |
| Jan 21, 2026 | Acacia Clinics and Vagus Nerve Society Conduct Study Using electroCore's gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder ("PTSD") | +10.2% | +1.2% |
| Jan 20, 2026 | electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 Million | -3.6% | -2.0% |
| Dec 2, 2025 | TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen | -0.4% | +0.2% |
| Nov 11, 2025 | electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum | +1.3% | +0.2% |
Quantisnow market dataNASDAQ
ECOR
electroCore Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Listed since
- 2018
Get push alerts for ECOR
Full ECOR profile on Quantisnow Follow ECOR and get a push notification the moment its next story breaks.